Key facts
- Midi Health’s last known valuation is $1.1B (Dec 2025).
- It has raised $254.1M across 1 recorded rounds; the latest was Early Stage VC ($13.9M) in Oct 2022.
- Notable investors include GV, Goodwater Capital, Felicis, City Light Capital, Emerson Collective — 48 tracked in total.
- Midi Health has filed 1 Form D with the SEC, most recently Mar 2023 ($13.9M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 48 names
- ·Watchlist + deal alerts for Midi Health
Funding rounds
1 roundsAbout Midi Health
Developer of a virtual care clinical platform designed to treat women with menopause and other health issues. The company's platform offers personalized expert protocols delivered by clinicians trained in female midlife health and leverages specialized at-home labs, prescription medications, supplements, and lifestyle coaching, enabling women to manage the challenges faced in the critical stages of their lives and careers.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2021
- Employees
- 870
- Website
- joinmidi.com/
- Ownership
- Privately Held (backing)
Midi Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Midi Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Midi Health in its N-PORT filings yet. We sweep new filings monthly.